These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34707066)

  • 21. Application of the Modified High Bleeding Risk Criteria for Japanese Patients in an All-Comers Registry of Percutaneous Coronary Intervention　- From the CREDO-Kyoto Registry Cohort-3.
    Natsuaki M; Morimoto T; Shiomi H; Ehara N; Taniguchi R; Tamura T; Tada T; Suwa S; Kaneda K; Watanabe H; Tazaki J; Watanabe S; Yamamoto E; Saito N; Fuki M; Takeda T; Eizawa H; Shinoda E; Mabuchi H; Shirotani M; Uegaito T; Matsuda M; Takahashi M; Inoko M; Tamura T; Ishii K; Onodera T; Sakamoto H; Aoyama T; Sato Y; Ando K; Furukawa Y; Nakagawa Y; Kadota K; Kimura T;
    Circ J; 2021 May; 85(6):769-781. PubMed ID: 33298644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bleeding events and mid-term mortality in the patients undergoing endovascular interventions for peripheral artery disease of the lower limbs based on the academic research consortium high bleeding risk criteria.
    Yoshioka N; Takagi K; Morita Y; Kanzaki Y; Nagai H; Watanabe N; Morishima I
    Heart Vessels; 2021 Sep; 36(9):1336-1349. PubMed ID: 33616719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the Academic Research Consortium for High Bleeding Risk criteria in Chinese patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention.
    Lyu SQ; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Yang YM
    Thromb Res; 2022 Jan; 209():16-22. PubMed ID: 34844044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Academic Research Consortium for High Bleeding Risk Definitions for Early, Late, and Very Late Bleeding Events.
    Miura K; Shima Y; Okabe K; Taguchi Y; Ikuta A; Takahashi K; Kubo S; Tada T; Tanaka H; Fuku Y; Kadota K
    Circ J; 2021 May; 85(6):797-805. PubMed ID: 33853992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores.
    Ueki Y; Bär S; Losdat S; Otsuka T; Zanchin C; Zanchin T; Gragnano F; Gargiulo G; Siontis GCM; Praz F; Lanz J; Hunziker L; Stortecky S; Pilgrim T; Heg D; Valgimigli M; Windecker S; Räber L
    EuroIntervention; 2020 Aug; 16(5):371-379. PubMed ID: 32065586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the Domestic High Bleeding Risk Criteria for Japanese Patients with Acute Myocardial Infarction.
    Matsumoto T; Saito Y; Sato T; Yamashita D; Suzuki S; Saito K; Wakabayashi S; Kitahara H; Sano K; Kobayashi Y
    J Atheroscler Thromb; 2023 Mar; 30(3):299-309. PubMed ID: 35613875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and outcomes of high bleeding risk patients with type 1 and type 2 myocardial infarction in a community-based cohort: Application of the Academic Research Consortium High Bleeding Risk Criteria.
    Breen TJ; Raphael CE; Ingraham B; Lane C; Huxley S; Roger VL; Jaffe A; Lewis B; Sandoval YB; Prasad A; Rihal CS; Gulati R; Singh M
    Int J Cardiol; 2024 Feb; 396():131565. PubMed ID: 37913957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive Ability of Academic Research Consortium for High Bleeding Risk Criteria in ST-Elevation Myocardial Infarction Patients Undergoing Primary Coronary Intervention.
    Fujii T; Ikari Y
    Circ J; 2021 Jan; 85(2):159-165. PubMed ID: 33177266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR.
    Escaned J; Cao D; Baber U; Nicolas J; Sartori S; Zhang Z; Dangas G; Angiolillo DJ; Briguori C; Cohen DJ; Collier T; Dudek D; Gibson M; Gil R; Huber K; Kaul U; Kornowski R; Krucoff MW; Kunadian V; Mehta S; Moliterno DJ; Ohman EM; Oldroyd KG; Sardella G; Sharma SK; Shlofmitz R; Weisz G; Witzenbichler B; Pocock S; Mehran R
    Eur Heart J; 2021 Dec; 42(45):4624-4634. PubMed ID: 34662382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the ARC-HBR criteria in 68,874 patients undergoing PCI: A systematic review and meta-analysis.
    Montalto C; Munafò AR; Arzuffi L; Casula M; Mandurino-Mirizzi A; Costa F; Leonardi S; Oltrona Visconti L; Ferlini M
    Hellenic J Cardiol; 2022; 66():59-66. PubMed ID: 35550178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definition.
    Gragnano F; Spirito A; Corpataux N; Vaisnora L; Galea R; Gargiulo G; Siontis GCM; Praz F; Lanz J; Billinger M; Hunziker L; Stortecky S; Pilgrim T; Bär S; Ueki Y; Capodanno D; Urban P; Pocock SJ; Mehran R; Heg D; Windecker S; Räber L; Valgimigli M
    EuroIntervention; 2021 Dec; 17(11):e898-e909. PubMed ID: 34105513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of the Japanese high bleeding risk criteria and its prognostic significance for fatal bleeding in patients with acute myocardial infarction.
    Sotomi Y; Hikoso S; Nakatani D; Suna S; Dohi T; Mizuno H; Okada K; Kida H; Oeun B; Sunaga A; Sato T; Kitamura T; Sakata Y; Sato H; Hori M; Komuro I; Sakata Y;
    Heart Vessels; 2021 Oct; 36(10):1484-1495. PubMed ID: 33743047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ischemic and Bleeding Events in PENDULUM Patients With High Bleeding Risk and High Platelet Reactivity.
    Iijima R; Kadota K; Nakao K; Nakagawa Y; Shite J; Yokoi H; Kozuma K; Tanabe K; Akasaka T; Shinke T; Ueno T; Hirayama A; Uemura S; Harada A; Kuroda T; Takita A; Murakami Y; Saito S; Nakamura M
    Circ J; 2022 Apr; 86(5):763-771. PubMed ID: 34880154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contribution of ESC DAPT guideline-endorsed high thrombotic risk features to long-term clinical outcomes among patients with and without high bleeding risk after PCI.
    Wang HY; Dou KF; Yin D; Zhang D; Gao RL; Yang YJ
    BMC Cardiovasc Disord; 2020 Jul; 20(1):313. PubMed ID: 32611318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Outcomes Based on High Bleeding Risk in Patients With Lower Extremity Peripheral Artery Disease Who Have Undergone Endovascular Therapy.
    Yoshioka N; Tokuda T; Koyama A; Yamada T; Shimamura K; Nishikawa R; Morita Y; Morishima I
    J Endovasc Ther; 2023 May; ():15266028231176953. PubMed ID: 37246791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PRECISE-DAPT and ARC-HBR Predict in-Hospital Outcomes in Patients Who Underwent Percutaneous Coronary Intervention.
    Kadiyala V; Long S; Has P; Lima FV; Sherrod CF; Heinl R; Williams MU; Nowak E; Kennedy K; Aronow HD; Abbott JD
    Am J Cardiol; 2023 Mar; 191():43-50. PubMed ID: 36640599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malnutrition-associated high bleeding risk with low thrombogenicity in patients undergoing percutaneous coronary intervention.
    Nakanishi N; Kaikita K; Ishii M; Kuyama N; Tabata N; Ito M; Yamanaga K; Fujisue K; Hoshiyama T; Kanazawa H; Hanatani S; Sueta D; Takashio S; Arima Y; Araki S; Usuku H; Nakamura T; Suzuki S; Yamamoto E; Soejima H; Matsushita K; Tsujita K
    Nutr Metab Cardiovasc Dis; 2022 May; 32(5):1227-1235. PubMed ID: 35197212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practical Assessment of the Tradeoff between Fatal Bleeding and Coronary Thrombotic Risks using the Academic Research Consortium for High Bleeding Risk Criteria.
    Sotomi Y; Hikoso S; Nakatani D; Dohi T; Mizuno H; Okada K; Kida H; Oeun B; Sunaga A; Sato T; Kitamura T; Sakata Y; Sato H; Hori M; Komuro I; Sakata Y
    J Atheroscler Thromb; 2022 Aug; 29(8):1236-1248. PubMed ID: 34526434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of the Academic Research Consortium High Bleeding Risk Criteria in Patients With ST-Segment Elevation Myocardial Infarction: A Single Center Study.
    Inan D; Yumurtas AC; Simsek B; Palice A; Efendioglu EM; Yuksel G; Korkmaz B; Vatanoglu EG; Güngör B; Karabay CY
    Angiology; 2024 Feb; 75(2):166-174. PubMed ID: 36314105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.
    Sorrentino S; Claessen BE; Chandiramani R; Guedeney P; Vogel B; Baber U; Rau V; Wang J; Krucoff M; Kozuma K; Ge J; Seth A; Makkar R; Liu Y; Bangalore S; Bhatt DL; Angiolillo DJ; Saito S; Neumann FJ; Hermiller J; Valgimigli M; Mehran R
    Circulation; 2020 Mar; 141(11):891-901. PubMed ID: 31992063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.